FDA Approves Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

FDA Approves Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma DUBLIN, June 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) approval of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for use as a component of a multi-agent chemotherapeutic regimen for… Read More »

Crowded parties and coronavirus concerns keep high schoolers from returning to the classroom

Their study, published last Thursday in the Journal of Medical Internet Research, found a statistically significant increase in clinic and hospital visits by patients who reported respiratory illnesses as early as the week of December 22. The first known case of Covid-19 in the US was thought to be a patient in Washington who had… Read More »

Democrats forcing clampdown on vaping industry marketing to children

Democrats are stepping up efforts to clamp down on e-cigarette makers’ marketing practices that they argue target children, a public health issue that is returning to the political agenda after being pushed to the back burner by the pandemic. North Carolina Attorney General Josh Stein, a Democrat, settled the first state-initiated lawsuit against Juul, the… Read More »

  1. Pages:
  3. 1
  4. ...
  5. 83
  6. 84
  7. 85
  8. 86
  9. 87
  10. 88
  11. 89
  12. ...
  13. 1458